Defense Health Agency Contracting Activity - DHACA Grants

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Care Award funds clinical research and clinical trials evaluating interventions and solutions in dementia care for individuals with Alzheimer's disease and related dementias and their care partners. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Trials solely testing pharmacological interventions and studies using animal models do not meet the intent, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Kidney Cancer Research Program Idea Development Award funds high-impact, hypothesis-driven research that advances understanding of kidney cancer and aims to improve patient outcomes. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, and a partnering PI option supports two-investigator collaborations. Project teams are expected to have a strong kidney cancer research background. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of Defense (CDMRP) Kidney Cancer Research Program Academy of Kidney Cancer Investigators Early-Career Scholar Award supports junior faculty through a virtual academy that pairs early-career scholars with established mentors and emphasizes both research and career development in kidney cancer. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement, but the award is geared toward early-career investigators. Preliminary data are required, though they need not come from the kidney cancer field. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Breast Cancer Research Program Breakthrough Award Level 3 supports promising research with high potential to lead to breakthroughs in breast cancer. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Small-scale clinical trials are allowed but not required, and the research team must include two or more breast cancer consumer advocates. No specific award amount is stated; applications must address an FY26 BCRP overarching challenge.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) ALS Research Program Therapeutic Development Award supports research from preclinical validation of therapeutic leads through FDA IND-enabling studies, with product-driven, empirical projects. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Applicants must begin with lead compounds in hand and already-demonstrated proof-of-concept efficacy in a preclinical ALS model; candidates already granted an IND are not appropriate. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Breast Cancer Research Program Breakthrough Award Level 4 supports promising research with high potential for breakthroughs in breast cancer. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Clinical trials are required for this level, and the research team must include two or more breast cancer consumer advocates. Up to two partnering Principal Investigators are allowed. No specific award amount is stated; applications must address an FY26 BCRP overarching challenge.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Transformative Breast Cancer Consortium Award supports highly integrated, multidisciplinary, multi-institutional consortia addressing major problems in breast cancer. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Applications must include at least one breast cancer consumer advocate per project team and may involve up to five Principal Investigators. No specific award amount is stated; review the full opportunity for the consortium structure and submission requirements.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) ALS Research Program Clinical Outcomes and Biomarkers Award supports development and validation of clinical outcomes and biomarkers to enrich ALS clinical trials. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Projects may target a specific therapy, therapeutic class, or ALS subtype and may use digital health measures. Community collaboration informed by the ALS lived-experience community is expected. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) ALS Research Program Therapeutic Idea Award supports new, innovative, high-risk/high-reward ideas aimed at ALS drug or therapy discovery, with hypothesis-driven studies generating preliminary data. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Preliminary data are not required; the application's strength should rely on the approach. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Rare Cancers Research Program Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Preliminary data are not required, and the review is blinded, so identifying the PI, collaborators, or their organizations in the application is prohibited and will result in rejection. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) ALS Research Program Pilot Clinical Trial Award supports rapid implementation of phase 1 to small-scale phase 2 trials affecting ALS treatment or management. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Applications must address biomarker-driven interventions or clinical care, incorporate community collaboration, and include a regulatory strategy and transition plan. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Ovarian Cancer Investigator-Initiated Research Award supports high-impact research from basic laboratory through translational work, excluding clinical trials. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Preliminary data are required, and a Partnering PI option allows two investigators to work synergistically on a single project. No specific award amount is stated; review the full opportunity for requirements.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Ovarian Cancer Pilot Award supports research exploring innovative concepts or theories that could expand or modify current thinking in ovarian cancer. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Innovation is central; preliminary data are not required but allowed. A blinded pre-application screening means no PI, collaborator, or organization identifying material should be included at that stage. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Ovarian Cancer Clinical Trial Academy Early-Career Investigator Award supports junior clinical trialists through a virtual academy providing mentoring, networking, and training to run ovarian cancer clinical trials. Eligibility is described as unrestricted (open to any entity type), subject to clarifications, but the award targets Early-Career Investigators within 12 years of their last postdoctoral or fellowship position who must commit at least 25% effort. Preliminary data are required. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Ovarian Cancer Academy Early-Career Investigator Award supports junior faculty through a virtual academy offering mentoring, networking, and collaboration alongside ovarian cancer research. Eligibility is described as unrestricted (open to any entity type), subject to clarifications, but the award is aimed at Early-Career Investigators who must participate in monthly webinars and annual workshops with a designated mentor. No specific award amount is stated; this is a career-development-oriented mechanism.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Ovarian Cancer Clinical Trial Award supports rapid implementation of clinical trials with potential to significantly affect ovarian cancer treatment or management. Eligibility is described as unrestricted (open to any entity type), subject to clarifications in the announcement. Trials may range from small proof-of-concept studies through large-scale efficacy trials. No specific award amount is stated; review the full funding opportunity for requirements.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Impact Award supports mature research with near-term potential to affect clinical cancer care within congressionally directed FY26 topic areas. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Applications must include preliminary data supporting feasibility; clinical trials are allowed. Up to two partnering Principal Investigators are permitted. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Clinical Trial Award funds clinical trials (phase 0 through phase III) testing new products, drugs, devices, or approaches to treat or manage cancer within designated topic areas. Applications must include a clinical trial and patient advocates, animal studies are not allowed, and any required IND/IDE regulatory application must be submitted by the application deadline. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. No specific award amount is stated in this record.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Peer Reviewed Cancer Research Program Idea Award supports innovative, untested, high-risk/high-reward concepts and basic cancer research relevant to the Military Health System. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Preliminary data are not required, but a strong scientific rationale is. A new Early Career Investigator option supports promising investigators early in faculty appointments. No specific award amount is stated.

Defense Health Agency Contracting Activity - DHACA · Amount varies

This Department of War (Defense Health Agency) Pancreatic Cancer Research Program Focused Pilot Award supports exploratory, innovative pancreatic cancer research intended to produce preliminary data for future work; preliminary data are allowed but not required. Clinical research studies are permitted, but clinical trials are not allowed and preclinical animal-only studies do not meet the intent. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. No specific award amount is stated in this record.